Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 350

1.

Repetitive transcranial magnetic stimulation (rTMS) for schizophrenia patients treated with clozapine.

Wagner E, Honer WG, Sommer IE, Koops S, Blumberger DM, Daskalakis ZJ, Dlabac-De Lange JJ, Bais L, Knegtering H, Aleman A, Novak T, Klirova M, Slotema C, Brunelin J, Poulet E, Kujovic M, Cordes J, Wobrock T, Siskind D, Falkai P, Schneider-Axmann T, Hasan A.

World J Biol Psychiatry. 2020 Mar 13:1-13. doi: 10.1080/15622975.2020.1733080. [Epub ahead of print]

PMID:
32081071
2.

Clozapine-Associated Obsessive-Compulsive Symptoms and Their Management: A Systematic Review and Analysis of 107 Reported Cases.

Kim DD, Barr AM, Lu C, Stewart SE, White RF, Honer WG, Procyshyn RM.

Psychother Psychosom. 2020 Feb 11:1-10. doi: 10.1159/000505876. [Epub ahead of print] Review.

PMID:
32045914
3.

Cognitive decline and mortality in a community-based sample of homeless and precariously housed adults: 9-year prospective study.

Gicas KM, Jones AA, Thornton AE, Petersson A, Livingston E, Waclawik K, Panenka WJ, Barr AM, Lang DJ, Vila-Rodriguez F, Leonova O, Procyshyn RM, Buchanan T, MacEwan GW, Honer WG.

BJPsych Open. 2020 Feb 11;6(2):e21. doi: 10.1192/bjo.2020.3.

4.

Traumatic brain injury in homeless and marginally housed individuals: a systematic review and meta-analysis.

Stubbs JL, Thornton AE, Sevick JM, Silverberg ND, Barr AM, Honer WG, Panenka WJ.

Lancet Public Health. 2020 Jan;5(1):e19-e32. doi: 10.1016/S2468-2667(19)30188-4. Epub 2019 Dec 2. Erratum in: Lancet Public Health. 2019 Dec 18;:.

5.

Decreased medial entorhinal cortical thickness in olanzapine exposed female rats is not ameliorated by exercise.

Woodward ML, Ker AH, Barr AM, Beasley CL, Hercher C, Boyda HN, Procyshyn RM, Honer WG, Lang DJ.

Pharmacol Biochem Behav. 2020 Jan;188:172834. doi: 10.1016/j.pbb.2019.172834. Epub 2019 Nov 27.

PMID:
31785244
6.

Preliminary examination of the validity of the NIH toolbox cognition battery in treatment-resistant psychosis.

Cassetta BD, Menon M, Carrion PB, Pearce H, DeGraaf A, Leonova O, White RF, Stowe RM, Honer WG, Woodward TS, Torres IJ.

Clin Neuropsychol. 2019 Nov 29:1-23. doi: 10.1080/13854046.2019.1694072. [Epub ahead of print]

PMID:
31782350
7.

The synaptic pathology of cognitive life
.

Honer WG, Ramos-Miguel A, Alamri J, Sawada K, Barr AM, Schneider JA, Bennett DA.

Dialogues Clin Neurosci. 2019 Sep;21(3):271-279. doi: 10.31887/DCNS.2019.21.3/whoner.

8.

Neurocognitive risk markers in pediatric obsessive-compulsive disorder.

Negreiros J, Belschner L, Best JR, Lin S, Franco Yamin D, Joffres Y, Selles RR, Jaspers-Fayer F, Miller LD, Woodward TS, Honer WG, Stewart SE.

J Child Psychol Psychiatry. 2019 Nov 20. doi: 10.1111/jcpp.13153. [Epub ahead of print]

PMID:
31749150
9.

Characterization of mental health in cannabis dispensary users, using structured clinical interviews and standardized assessment instruments.

Yau JC, Yu SM, Panenka WJ, Pearce H, Gicas KM, Procyshyn RM, MacCallum C, Honer WG, Barr AM.

BMC Psychiatry. 2019 Nov 1;19(1):335. doi: 10.1186/s12888-019-2324-z.

10.

Cognitive Impairment in Marginally Housed Youth: Prevalence and Risk Factors.

Waclawik K, Jones AA, Barbic SP, Gicas KM, O'Connor TA, Smith GN, Leonova O, Mathias S, Barr AM, Procyshyn RM, Lang DJ, Woodward ML, MacEwan GW, Panenka WJ, Yamamoto A, Honer WG, Thornton AE.

Front Public Health. 2019 Oct 8;7:270. doi: 10.3389/fpubh.2019.00270. eCollection 2019.

11.

Editorial on the Special Issue on SNARE Proteins: A Long Journey of Science in Brain Health and Disease.

Matteoli M, Menna E, Honer WG, Fernández-Chacón R.

Neuroscience. 2019 Nov 10;420:1-3. doi: 10.1016/j.neuroscience.2019.10.004. Epub 2019 Oct 18. No abstract available.

PMID:
31634514
12.

Social and structural factors associated with substance use within the support network of adults living in precarious housing in a socially marginalized neighborhood of Vancouver, Canada.

Knerich V, Jones AA, Seyedin S, Siu C, Dinh L, Mostafavi S, Barr AM, Panenka WJ, Thornton AE, Honer WG, Rutherford AR.

PLoS One. 2019 Sep 23;14(9):e0222611. doi: 10.1371/journal.pone.0222611. eCollection 2019.

13.

A comparison of the effects of clozapine and its metabolite norclozapine on metabolic dysregulation in rodent models.

Yuen JWY, Wu C, Wang CK, Kim DD, Procyshyn RM, Honer WG, Barr AM.

Neuropharmacology. 2019 Jul 23:107717. doi: 10.1016/j.neuropharm.2019.107717. [Epub ahead of print] Review.

PMID:
31348941
14.

Prevalence and Risk Factors of Brain Infarcts and Associations With Cognitive Performance in Tenants of Marginal Housing.

Zhou LW, Panenka WJ, Jones AA, Gicas KM, Thornton AE, Heran MKS, Volders D, Lang DJ, Vertinsky AT, Rauscher A, Su W, Barr AM, MacEwan GW, Honer WG, Field TS.

J Am Heart Assoc. 2019 Jul 2;8(13):e011412. doi: 10.1161/JAHA.118.011412. Epub 2019 Jun 27.

15.

A comparison of regional brain volumes and white matter connectivity in subjects with stimulant induced psychosis versus schizophrenia.

Alexander PD, Gicas KM, Cheng A, Lang DJ, Procyshyn RM, Vertinsky AT, Panenka WJ, Thornton AE, Rauscher A, Wong JYX, Chan T, Jones AA, Vila-Rodriguez F, Honer WG, Barr AM.

Psychopharmacology (Berl). 2019 Dec;236(12):3385-3399. doi: 10.1007/s00213-019-05298-w. Epub 2019 Jun 22.

PMID:
31230145
16.

Cognitive profiles and associated structural brain networks in a multimorbid sample of marginalized adults.

Gicas KM, Jones AA, Panenka WJ, Giesbrecht C, Lang DJ, Vila-Rodriguez F, Leonova O, Barr AM, Procyshyn RM, Su W, Rauscher A, Vertinsky AT, Buchanan T, MacEwan GW, Thornton AE, Honer WG.

PLoS One. 2019 Jun 13;14(6):e0218201. doi: 10.1371/journal.pone.0218201. eCollection 2019.

17.

Human Hippocampal Neurogenesis Persists in Aged Adults and Alzheimer's Disease Patients.

Tobin MK, Musaraca K, Disouky A, Shetti A, Bheri A, Honer WG, Kim N, Dawe RJ, Bennett DA, Arfanakis K, Lazarov O.

Cell Stem Cell. 2019 Jun 6;24(6):974-982.e3. doi: 10.1016/j.stem.2019.05.003. Epub 2019 May 23.

PMID:
31130513
18.

Parcellation of the human hippocampus based on gray matter volume covariance: Replicable results on healthy young adults.

Ge R, Kot P, Liu X, Lang DJ, Wang JZ, Honer WG, Vila-Rodriguez F.

Hum Brain Mapp. 2019 Sep;40(13):3738-3752. doi: 10.1002/hbm.24628. Epub 2019 May 22.

PMID:
31115118
19.

Brain IGFBP-5 modifies the relation of depressive symptoms to decline in cognition in older persons.

Capuano AW, Wilson RS, Honer WG, Petyuk VA, Leurgans SE, Yu L, Gatchel JR, Arnold S, Bennett DA, Arvanitakis Z.

J Affect Disord. 2019 May 1;250:313-318. doi: 10.1016/j.jad.2019.03.051. Epub 2019 Mar 8.

PMID:
30875674
20.

Association between Serum Lipids and Antipsychotic Response in Schizophrenia.

Kim DD, Barr AM, Fredrikson DH, Honer WG, Procyshyn RM.

Curr Neuropharmacol. 2019;17(9):852-860. doi: 10.2174/1570159X17666190228113348. Review.

21.

Diffusion tensor imaging of neurocognitive profiles in a community cohort living in marginal housing.

Gicas KM, Cheng A, Rawtaer I, Willi TS, Panenka WJ, Lang DJ, Smith GN, Vila-Rodriguez F, Leonova O, Giesbrecht CJ, Jones AA, Barr AM, Procyshyn RM, Buchanan T, MacEwan GW, Su W, Vertinsky AT, Rauscher A, O'Rourke N, Loken Thornton W, Thornton AE, Honer WG.

Brain Behav. 2019 Mar;9(3):e01233. doi: 10.1002/brb3.1233. Epub 2019 Feb 6.

22.

Efficacy of high-frequency repetitive transcranial magnetic stimulation in schizophrenia patients with treatment-resistant negative symptoms treated with clozapine.

Wagner E, Wobrock T, Kunze B, Langguth B, Landgrebe M, Eichhammer P, Frank E, Cordes J, Wölwer W, Winterer G, Gaebel W, Hajak G, Ohmann C, Verde PE, Rietschel M, Ahmed R, Honer WG, Siskind D, Malchow B, Strube W, Schneider-Axmann T, Falkai P, Hasan A.

Schizophr Res. 2019 Jun;208:370-376. doi: 10.1016/j.schres.2019.01.021. Epub 2019 Jan 29.

PMID:
30704862
23.

Clozapine augmentation strategies - a systematic meta-review of available evidence. Treatment options for clozapine resistance.

Wagner E, Löhrs L, Siskind D, Honer WG, Falkai P, Hasan A.

J Psychopharmacol. 2019 Apr;33(4):423-435. doi: 10.1177/0269881118822171. Epub 2019 Jan 30.

PMID:
30696332
24.

The SNAP25 Interactome in Ventromedial Caudate in Schizophrenia Includes the Mitochondrial Protein ARF1.

Ramos-Miguel A, Barakauskas V, Alamri J, Miyauchi M, Barr AM, Beasley CL, Rosoklija G, Mann JJ, Dwork AJ, Moradian A, Morin GB, Honer WG.

Neuroscience. 2019 Nov 10;420:97-111. doi: 10.1016/j.neuroscience.2018.12.045. Epub 2019 Jan 2.

PMID:
30610939
25.

Reduced SNAP25 Protein Fragmentation Contributes to SNARE Complex Dysregulation in Schizophrenia Postmortem Brain.

Ramos-Miguel A, Gicas K, Alamri J, Beasley CL, Dwork AJ, Mann JJ, Rosoklija G, Cai F, Song W, Barr AM, Honer WG.

Neuroscience. 2019 Nov 10;420:112-128. doi: 10.1016/j.neuroscience.2018.12.015. Epub 2018 Dec 21.

PMID:
30579835
26.

Clozapine-induced obsessive–compulsive symptoms: mechanisms and treatment

Kim DD, Barr AM, White RF, Honer WG, Procyshyn RM.

J Psychiatry Neurosci. 2019 Jan 1;44(1):71-72. No abstract available.

27.

Factors Associated With Successful Medication Discontinuation After a Randomized Clinical Trial of Relapse Prevention in First-Episode Psychosis: A 10-Year Follow-up.

Hui CLM, Honer WG, Lee EHM, Chang WC, Chan SKW, Chen EYH.

JAMA Psychiatry. 2019 Feb 1;76(2):217-219. doi: 10.1001/jamapsychiatry.2018.3120. No abstract available.

28.

Hippocampal volume and vasculature before and after exercise in treatment-resistant schizophrenia.

Woodward ML, Gicas KM, Warburton DE, White RF, Rauscher A, Leonova O, Su W, Smith GN, Thornton AE, Vertinsky AT, Phillips AA, Goghari VM, Honer WG, Lang DJ.

Schizophr Res. 2018 Dec;202:158-165. doi: 10.1016/j.schres.2018.06.054. Epub 2018 Jun 29.

PMID:
30539767
29.

Rapid agitation control with ketamine in the emergency department (RACKED): a randomized controlled trial protocol.

Barbic D, Andolfatto G, Grunau B, Scheuermeyer FX, MacEwan W, Honer WG, Wong H, Barbic SP.

Trials. 2018 Nov 26;19(1):651. doi: 10.1186/s13063-018-2992-x.

30.

Weight gain as a predictor of frontal and temporal lobe volume loss in bipolar disorder: A prospective MRI study.

Bond DJ, Su W, Honer WG, Dhanoa T, Batres-Y-Carr T, Lee SS, Torres IJ, Lam RW, Yatham LN.

Bipolar Disord. 2019 Feb;21(1):50-60. doi: 10.1111/bdi.12722. Epub 2018 Dec 1.

PMID:
30422375
31.

Volumes of the Hippocampal Formation Differentiate Component Processes of Memory in a Community Sample of Homeless and Marginally Housed Persons.

Gicas KM, Thornton AE, Waclawik K, Wang N, Jones AA, Panenka WJ, Lang DJ, Smith GN, Vila-Rodriguez F, Leonova O, Barr AM, Procyshyn RM, Buchanan T, Su W, Vertinsky AT, Rauscher A, MacEwan GW, Honer WG.

Arch Clin Neuropsychol. 2019 Jun 1;34(4):548-562. doi: 10.1093/arclin/acy066.

PMID:
30407496
32.

Predicting first-episode psychosis patients who will never relapse over 10 years.

Hui CL, Honer WG, Lee EH, Chang WC, Chan SK, Chen ES, Pang EP, Lui SS, Chung DW, Yeung WS, Ng RM, Lo WT, Jones PB, Sham P, Chen EY.

Psychol Med. 2019 Oct;49(13):2206-2214. doi: 10.1017/S0033291718003070. Epub 2018 Oct 30.

PMID:
30375301
33.

Left prefrontal high-frequency rTMS may improve movement disorder in schizophrenia patients with predominant negative symptoms - A secondary analysis of a sham-controlled, randomized multicenter trial.

Kamp D, Engelke C, Wobrock T, Wölwer W, Winterer G, Schmidt-Kraepelin C, Gaebel W, Langguth B, Landgrebe M, Eichhammer P, Frank E, Hajak G, Ohmann C, Verde PE, Rietschel M, Raees A, Honer WG, Malchow B, Schneider-Axmann T, Falkai P, Hasan A, Cordes J.

Schizophr Res. 2019 Feb;204:445-447. doi: 10.1016/j.schres.2018.09.017. Epub 2018 Sep 22. No abstract available.

PMID:
30249471
34.

Antipsychotic-Associated Symptoms of Tourette Syndrome: A Systematic Review.

Kim DD, Barr AM, Chung Y, Yuen JWY, Etminan M, Carleton BC, White RF, Honer WG, Procyshyn RM.

CNS Drugs. 2018 Oct;32(10):917-938. doi: 10.1007/s40263-018-0559-8.

PMID:
30121819
35.

Antipsychotic prescribing patterns on admission to and at discharge from a tertiary care program for treatment-resistant psychosis.

Lee LHN, Procyshyn RM, White RF, Woodward TS, Honer WG, Barr AM.

PLoS One. 2018 Aug 10;13(8):e0199758. doi: 10.1371/journal.pone.0199758. eCollection 2018.

36.

A systematic review of the effects of CYP2D6 phenotypes on risperidone treatment in children and adolescents.

Dodsworth T, Kim DD, Procyshyn RM, Ross CJ, Honer WG, Barr AM.

Child Adolesc Psychiatry Ment Health. 2018 Jul 16;12:37. doi: 10.1186/s13034-018-0243-2. eCollection 2018. Review.

37.

Reversal of Dopamine Supersensitivity as a Mechanism of Action of Clozapine.

Kim DD, Barr AM, Honer WG, Procyshyn RM.

Psychother Psychosom. 2018;87(5):306-307. doi: 10.1159/000491700. Epub 2018 Jul 19. No abstract available.

PMID:
30025405
38.

Clinical and functional characteristics of young adults living in single room occupancy housing: preliminary findings from a 10-year longitudinal study.

Barbic SP, Jones AA, Woodward M, Piercy M, Mathias S, Vila-Rodriguez F, Leonova O, Smith GN, Buchanan T, Vertinsky AT, Gillingham S, Panenka WJ, Rauscher A, Barr AM, Procyshyn RM, MacEwan GW, Lang DJ, Thornton AE, Heran MK, Leon AM, Krausz M, Honer WG.

Can J Public Health. 2018 Apr;109(2):204-214. doi: 10.17269/s41997-018-0087-9. Epub 2018 May 31.

39.

Musical disability in children with autism spectrum disorder.

Sota S, Hatada S, Honjyo K, Takatsuka T, Honer WG, Morinobu S, Sawada K.

Psychiatry Res. 2018 Sep;267:354-359. doi: 10.1016/j.psychres.2018.05.078. Epub 2018 Jun 19.

PMID:
29957553
40.

Clozapine-Induced Cardiovascular Side Effects and Autonomic Dysfunction: A Systematic Review.

Yuen JWY, Kim DD, Procyshyn RM, White RF, Honer WG, Barr AM.

Front Neurosci. 2018 Apr 4;12:203. doi: 10.3389/fnins.2018.00203. eCollection 2018.

41.

Statin add-on therapy for schizophrenia: Is the effect the same for clozapine?

Kim DD, Barr AM, Thornton AE, Honer WG, Procyshyn RM.

Psychiatry Res. 2018 May;263:289-290. doi: 10.1016/j.psychres.2018.02.039. Epub 2018 Mar 22. No abstract available.

PMID:
29566972
42.

Long-term effects of discontinuation from antipsychotic maintenance following first-episode schizophrenia and related disorders: a 10 year follow-up of a randomised, double-blind trial.

Hui CLM, Honer WG, Lee EHM, Chang WC, Chan SKW, Chen ESM, Pang EPF, Lui SSY, Chung DWS, Yeung WS, Ng RMK, Lo WTL, Jones PB, Sham P, Chen EYH.

Lancet Psychiatry. 2018 May;5(5):432-442. doi: 10.1016/S2215-0366(18)30090-7. Epub 2018 Mar 15.

PMID:
29551618
43.

Frontotemporal dysregulation of the SNARE protein interactome is associated with faster cognitive decline in old age.

Ramos-Miguel A, Jones AA, Sawada K, Barr AM, Bayer TA, Falkai P, Leurgans SE, Schneider JA, Bennett DA, Honer WG.

Neurobiol Dis. 2018 Jun;114:31-44. doi: 10.1016/j.nbd.2018.02.006. Epub 2018 Feb 26.

44.

Efficacy of high-frequency repetitive transcranial magnetic stimulation on PANSS factors in schizophrenia with predominant negative symptoms - Results from an exploratory re-analysis.

Hansbauer M, Wobrock T, Kunze B, Langguth B, Landgrebe M, Eichhammer P, Frank E, Cordes J, Wölwer W, Winterer G, Gaebel W, Hajak G, Ohmann C, Verde PE, Rietschel M, Ahmed R, Honer WG, Malchow B, Strube W, Schneider-Axmann T, Falkai P, Hasan A.

Psychiatry Res. 2018 May;263:22-29. doi: 10.1016/j.psychres.2018.02.030. Epub 2018 Feb 17.

PMID:
29482042
45.

Musical deficits and cortical thickness in people with schizophrenia.

Fujito R, Minese M, Hatada S, Kamimura N, Morinobu S, Lang DJ, Honer WG, Sawada K.

Schizophr Res. 2018 Jul;197:233-239. doi: 10.1016/j.schres.2018.01.027. Epub 2018 Feb 15.

PMID:
29454511
46.

Exercise-induced hippocampal neurogenesis: 5-HT3 receptor antagonism by antipsychotics as a potential limiting factor in Schizophrenia.

Kim DD, Barr AM, Honer WG, Procyshyn RM.

Mol Psychiatry. 2018 Dec;23(12):2252-2253. doi: 10.1038/s41380-018-0022-8. Epub 2018 Feb 8. No abstract available.

PMID:
29422519
47.

Reduced cardiovascular fitness associated with exposure to clozapine in individuals with chronic schizophrenia.

Kim DD, Lang DJ, Procyshyn RM, Woodward ML, Kaufman K, White RF, Honer WG, Warburton DER.

Psychiatry Res. 2018 Apr;262:28-33. doi: 10.1016/j.psychres.2018.01.029. Epub 2018 Jan 17.

PMID:
29407565
48.

Rapid Change in Fentanyl Prevalence in a Community-Based, High-Risk Sample.

Jones AA, Jang K, Panenka WJ, Barr AM, MacEwan GW, Thornton AE, Honer WG.

JAMA Psychiatry. 2018 Mar 1;75(3):298-300. doi: 10.1001/jamapsychiatry.2017.4432. No abstract available.

49.

Effects of physical activity on the symptoms of Tourette syndrome: A systematic review.

Kim DD, Warburton DER, Wu N, Barr AM, Honer WG, Procyshyn RM.

Eur Psychiatry. 2018 Feb;48:13-19. doi: 10.1016/j.eurpsy.2017.11.002. Epub 2018 Jan 10.

PMID:
29331594
50.

Verbal memory improvement in first-episode psychosis APOE-ε4 carriers: a pleiotropic effect?

Vila-Rodriguez F, Lang DJ, Baitz H, Gicas K, Thorton AE, Ehmann TS, Smith GN, Barr AM, Torres IJ, Kopala LC, MacEwan GW, Müller DJ, Kennedy JL, Honer WG.

Neuropsychiatr Dis Treat. 2017 Dec 8;13:2945–2953. doi: 10.2147/NDT.S150488. eCollection 2017.

Supplemental Content

Loading ...
Support Center